Siemens Healthineers will install MAMMOMAT Revelation mammography system at the Dili Medical Center, which will be Timor-Leste’s first mammography system. A mammography scan is a preferred screening method to examine the breast for early detection of cancer. With 141 new cases in 2022, breast cancer is the most common cancer among women in the country1.
“Currently, with no mammography system in Timor-Leste, patients with symptoms often travel to neighbouring countries for diagnosis and treatment. By installing this mammography system at Dili Medical Center, we are certainly overcoming the challenge of lack of accessibility to breast screening and are also dealing with managing the high incidences of breast cancer in the country. We are pleased to collaborate with Siemens Healthineers in bringing this system to Timor-Leste and we will be jointly working towards reducing the breast cancer mortality rates in the future.” Said Merry Monteiro, Chief Executive Officer at Dili Medical Center
More than 70 percent of Timor-Leste's total population resides in rural areas2, which makes Dili Medical Center the one of the private clinic who focuses on delivering best healthcare services and diagnostics in the country who is locally owned and run by Timor Leste. Nearly 650,000 women will now have access to high quality mammography screening. The Center will also focus on creating patient awareness and organize screening programs with an aim to screen 200 women per year.
"With this partnership, we are living our purpose of pioneering breakthroughs in healthcare for everyone, everywhere, sustainably. It is very fulfilling to install the country’s first mammography system at Dili Medical Center and helping them in the journey of fighting the leading cancer among women. Our collaboration is a significant step in improving women’s health by providing access to affordable cancer care in Timor-Leste, and it will continue in the future," said Alfred Fahringer, Country Head at Siemens Healthineers Indonesia.
MAMOMMAT Revelation is a state-of-the-art mammography system renowned for its exceptional image quality, low radiation dose, and ensuring the utmost comfort and safety for patients during breast screenings.
Source:
1. Globocan 2022
2. 2022 Census
About Siemens Healthineers
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com
Contact for media enquiries, please get in touch with:
Siemens Healthineers Indonesia
Evan Akira Zuraida
Head of Communications, Indonesia
Phone: +62 857 77673585; E-mail: evan.akira@siemens-healthineers.com